A Combination of Deferoxamine Mesylate and Minimally Invasive Surgery with Hematoma Lysis for Evacuation of Intracerebral Hemorrhage

Overview

Journal J Cereb Blood Flow Metab

Publisher Sage Publications

Specialties Cardiology & Vascular Diseases
Endocrinology
Neurology

Date 2019 Dec 4

PMID 31791162

Citations 8

Authors

Aditya S Pandey

Badih J Daou

Neeraj Chaudhary

Guohua Xi

Affiliations

Soon will be listed here.

Citing Articles

In situ implantable DNA hydrogel for diagnosis and therapy of postoperative rehemorrhage following intracerebral hemorrhage surgery.

Yu W, Gong E, Wang C, Che C, Zhao Y, Wu X Sci Adv. 2024; 10(33):eado3919.

PMID: 39141742 PMC: 11323940. DOI: 10.1126/sciadv.ado3919.

The Role of Iron in Hemorrhagic Stroke.

Koduri S, Keep R, Xi G, Chaudhary N, Pandey A Stroke Vasc Interv Neurol. 2023; 2(5).

PMID: 36590766 PMC: 9797125. DOI: 10.1161/svin.122.000419.

Efficacy of desferrioxamine mesylate in intracerebral hematoma: a systemic review and meta-analysis.

Zhao K, Li J, Zhang Q, Yang M Neurol Sci. 2022; 43(12):6771-6782.

PMID: 36006553 PMC: 9406250. DOI: 10.1007/s10072-022-06324-0.

Endogenous zinc protoporphyrin formation critically contributes to hemorrhagic stroke-induced brain damage.

Pan R, Yu S, Zhang H, Timmins G, Weaver J, Yang Y J Cereb Blood Flow Metab. 2021; 41(12):3232-3247.

PMID: 34187233 PMC: 8669275. DOI: 10.1177/0271678X211028475.

Assessing early erythrolysis and the relationship to perihematomal iron overload and white matter survival in human intracerebral hemorrhage.

Novakovic N, Wilseck Z, Chenevert T, Xi G, Keep R, Pandey A CNS Neurosci Ther. 2021; 27(10):1118-1126.

PMID: 34145764 PMC: 8446214. DOI: 10.1111/cns.13693.

References

Hanley D, Thompson R, Muschelli J, Rosenblum M, McBee N, Lane K . Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. Lancet Neurol. 2016; 15(12):1228-1237. PMC: 5154627. DOI: 10.1016/S1474-4422(16)30234-4. View

. Unmet Needs and Challenges in Clinical Research of Intracerebral Hemorrhage. Stroke. 2018; 49(5):1299-1307. PMC: 5916316. DOI: 10.1161/STROKEAHA.117.019541. View

Xu X, Chen X, Li F, Zheng X, Wang Q, Sun G . Effectiveness of endoscopic surgery for supratentorial hypertensive intracerebral hemorrhage: a comparison with craniotomy. J Neurosurg. 2017; 128(2):553-559. DOI: 10.3171/2016.10.JNS161589. View

van Asch C, Luitse M, Rinkel G, van der Tweel I, Algra A, Klijn C . Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010; 9(2):167-76. DOI: 10.1016/S1474-4422(09)70340-0. View

Hemphill 3rd J, Bonovich D, Besmertis L, Manley G, Johnston S . The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001; 32(4):891-7. DOI: 10.1161/01.str.32.4.891. View

Wilkinson D, Keep R, Hua Y, Xi G . Hematoma clearance as a therapeutic target in intracerebral hemorrhage: From macro to micro. J Cereb Blood Flow Metab. 2018; 38(4):741-745. PMC: 5888862. DOI: 10.1177/0271678X17753590. View

Selim M, Foster L, Moy C, Xi G, Hill M, Morgenstern L . Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2019; 18(5):428-438. PMC: 6494117. DOI: 10.1016/S1474-4422(19)30069-9. View

Mendelow A, Gregson B, Rowan E, Murray G, Gholkar A, Mitchell P . Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013; 382(9890):397-408. PMC: 3906609. DOI: 10.1016/S0140-6736(13)60986-1. View

Teernstra O, Evers S, Lodder J, Leffers P, Franke C, Blaauw G . Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke. 2003; 34(4):968-74. DOI: 10.1161/01.STR.0000063367.52044.40. View

10.

Hanley D, Thompson R, Rosenblum M, Yenokyan G, Lane K, McBee N . Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019; 393(10175):1021-1032. PMC: 6894906. DOI: 10.1016/S0140-6736(19)30195-3. View